Jean Jacques Bienaime - 15 Mar 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role: Chief Executive Officer, Director
Signature: /s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol: BMRN
Transactions as of: 15 Mar 2022
Net transactions value: -$3,447,014
Form type: 4
Filing time: 17 Mar 2022, 21:18:19 UTC
Previous filing: 14 Mar 2022
Next filing: 18 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BMRN	Common Stock	Award	$0	+40,280	+12%	$0.000000	378,849	15 Mar 2022	Direct	F1
transaction	BMRN	Common Stock	Tax liability	$2,998,211	-38,306	-10%	$78.27	340,543	15 Mar 2022	Direct
transaction	BMRN	Common Stock	Tax liability	$448,803	-5,560	-1.6%	$80.72	334,983	16 Mar 2022	Direct
holding	BMRN	Common Stock						247,533	15 Mar 2022	Shares held by Jean-Jacques Bienaime Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BMRN	Stock Option (Right to buy Common Stock)	Award	$0	+58,040		$0.000000	58,040	15 Mar 2022	Common Stock	58,040	$78.27	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units granted on March 15, 2022. Price not applicable.
F2	Option grant vests 12/36th on March 15, 2023 and 1/36th on the 15th day of each month thereafter.